Molecular risk stratification in CLL. Patients with CLL could be evaluated by sensitive next-generation sequencing for the mutations and deletions known to confer more aggressive disease and a poorer prognosis. The proposed risk stratification provides a hypothesis for analysis in a prospectively studied population.